相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation
Domenico Mastrangelo et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Double-blind, randomized crossover study of intravenous infusion of magnesium sulfate versus 5% dextrose on depressive symptoms in adults with treatment-resistant depression
Syed M. A. Mehdi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)
Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones
Pietro Manuel Ferraro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity
Lauren Rouleau et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Elimination of Ascorbic Acid After High-Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation
Torben K. Nielsen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial
L. John Hoffer et al.
PLOS ONE (2015)
Intravenous Vitamin C and Cancer: A Systematic Review
Heidi Fritz et al.
INTEGRATIVE CANCER THERAPIES (2014)
High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
Yan Ma et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
J. L. Welsh et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
Christopher M. Stephenson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine
Emily A. Minor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Convenient Method for Measuring Blood Ascorbate Concentrations in Patients Receiving High-Dose Intravenous Ascorbate
Yan Ma et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2013)
Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study
Laura D. K. Thomas et al.
JAMA INTERNAL MEDICINE (2013)
Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
Daniel A. Monti et al.
PLOS ONE (2012)
Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
Sebastian J. Padayatty et al.
PLOS ONE (2010)
Oxalic acid excretion after intravenous ascorbic acid administration
Line Robitaille et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
L. J. Hoffer et al.
ANNALS OF ONCOLOGY (2008)
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Q Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ascorbate increases human oxaluria and kidney stone risk
LK Massey et al.
JOURNAL OF NUTRITION (2005)
Vitamin C pharmacokinetics: Implications for oral and intravenous use
SJ Padayatty et al.
ANNALS OF INTERNAL MEDICINE (2004)
分享论文
